Free press releases distribution network?

Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits - AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits - AnaSpec.com
AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits

 

PRZOOM - /newswire/ - Fremont, CA, United States, 2013/02/07 - AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits - AnaSpec.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a fluorophore labeled substrate. Both substrates emit at the green emission wavelength of 520 nm (excitation at 490 nm); consequently, background fluorescence is lower. As well, both substrates provide minimal (if any) cross-reaction with other cathepsins.

The FRET peptide in the SensoLyte® 520 kit employs the QXL™ 520/HiLyte Fluor™ 488 pair for optimal quenching of the intact substrate. Hydrolysis of the FRET substrate by active Cathepsin L results in increase of HiLyte Fluor™ 488 fluorescence. Additionally, the fluorescent signal from HiLyte Fluor™ 488 is stable at low pH, the pH at which Cathepsin L activity is optimal. This homogeneous assay can be used for the detection of Cathepsin L activity in biological samples or in purified enzyme preparations. The SensoLyte® Rh110 Cathepsin L Activity Assay Kit provides a convenient assay for screening Cathepsin L inhibitors or assay of enzyme activity using Rh110 (rhodamine 110). Upon cleavage by Cathepsin L, this substrate generates Rh110 emitting bright green fluorescence.

Cathepsin L, a lysosomal endopeptidase, is a member of the papain-like family of cysteine proteinases (1). It is involved in the promotion of tumor cell invasion (2), antigen processing and turnover of intracellular and secreted proteins (3). It also plays a major role in growth regulation, bone resorption and metastasis (4, 5).

References:
1. Barrett, A.J. et al. Meth Enzymol 80, 535 (1981).
2. Gottesman, M.M. et al. Biochem 20, 1659 (1981).
3. Ishidoh, K. et al. Biochem Biophys Res Commun 217, 624 (1995).
4. Kane, S.E. et al. Semin Cancer Biol 1, 127 (1990).
5. Kirschke, H. et al. Eur J Cancer 36, 787 (2000).

About AnaSpec, EGT Group

AnaSpec, EGT Group is a leading provider of integrated proteomics and genomics solutions™ for worldwide life science research. AnaSpec (anaspec.com) offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCR MasterMixes. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Tiffany Kao - AnaSpec.com 
510-791-9560 cecilia[.]anaspec.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today